Brain Cancer Trial, Recruiting NCT06322602 Sponsor: Mayo Clinic Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06322602
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • There must be clinical signs and scan results suggesting the presence of a brain tumor.
  • A biopsy of a suspected or previously diagnosed brain tumor must already be planned as part of routine care at Mayo Clinic in Rochester, Minnesota.
  • The patient must be willing to give informed consent to participate.
  • The patient must be willing to have their Ommaya reservoir (a small device implanted in the head to access fluid) sampled on at least two future occasions.
  • The patient must be willing to have cerebrospinal fluid (the fluid surrounding the brain and spine) stored in a research tissue bank, which requires signing a separate consent form.

Who may not be able to join:

  • Adults who do not have the mental capacity to give informed consent for themselves may not be eligible.
  • People under 18 years old, pregnant women, and prisoners are not eligible.
  • People whose medical history or current health conditions make biopsy surgery unsuitable may not be eligible.
  • People who have had a wound infection at any point in the past may not be eligible.
  • People whom the surgeon considers not to be a good candidate for placement of the Ommaya reservoir device may not be eligible — reasons could include surgical anatomy, signs of a weakened immune system, or increased risk of wound infection due to factors such as diabetes, smoking history, or significant obesity (confirm with trial site for a full list of reasons).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
28 February 2024
Est. completion
1 March 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Ommaya reservoir placement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov